Skip Navigation
Skip to contents

J Korean Acad Nurs : Journal of Korean Academy of Nursing

OPEN ACCESS

Author index

Page Path
HOME > Browse articles > Author index
Search
Jung Ran Lee 2 Articles
A Structural Model for Chemotherapy Related Cognitive Impairment and Quality of Life in Breast Cancer Patients
Jung Ran Lee, Pok Ja Oh
J Korean Acad Nurs 2019;49(4):375-385.   Published online January 15, 2019
DOI: https://doi.org/10.4040/jkan.2019.49.4.375
AbstractAbstract PDF
Abstract Purpose

This study aimed to develop and test a structural model for chemotherapy-related cognitive impairment of breast cancer patients based on a literature review and Hess and Insel's chemotherapy-related cognitive change model.

Methods

The Participants consisted of 250 patients who were ≥19 years of age. The assessment tools included the Menopause Rating Scale, Symptom Experience Scale, Hospital Anxiety and Depression Scale, Everyday Cognition, and Functional Assessment of Cancer Therapy-Breast Cancer. Data were analyzed using the SPSS 21.0 and AMOS 21.0 programs.

Results

The modified model was a good fit for the data. The model fit indices were χ 2=423.18 (p<.001), χ 2/df=3.38, CFI=.91, NFI=.91, TLI=.89, SRMR=.05, RMSEA=.09, and AIC=515.18. Chemotherapy-related cognitive impairment was directly influenced by menopausal symptoms (β=.38, p=.002), depression and anxiety (β=.25, p=.002), and symptom experiences (β=.19, p=.012). These predictors explained 47.7% of the variance in chemotherapy-related cognitive impairment. Depression and anxiety mediated the relations among menopausal symptoms, symptom experiences, and with chemotherapy related cognitive impairment. Depression and anxiety (β=-.51, p=.001), symptom experiences (β=-.27, p=.001), menopausal symptoms (β=-.22, p=.008), and chemotherapy-related cognitive impairment (β=-.15, p=.024) had direct effects on the quality of life and these variables explained 91.3%.

Conclusion

These results suggest that chemotherapy-related toxicity is highly associated with cognitive decline and quality of life in women with breast cancer. Depression and anxiety increased vulnerability to cognitive impairment after chemotherapy. Nursing intervention is needed to relieve chemotherapy-related toxicity and psychological factor as well as cognitive decline for quality of life in patients undergoing chemotherapy.

Citations

Citations to this article as recorded by  
  • Analysis of Breast Cancer Nursing Education Content and Educational needs for Breast Cancer Patient Nursing Perceived by Nurses
    Young-Hee Je, Kyoung-Ah Kang
    Asian Oncology Nursing.2025; 25(1): 1.     CrossRef
  • Factors Influencing Oncofertility in Gynecological Cancer Patients: Application of Mixed Methods Study
    Minji Kim, Juyoung Ha
    Journal of Korean Academy of Nursing.2024; 54(3): 418.     CrossRef
  • Relationships Between Chemotherapy-Related Cognitive Impairment, Self-Care Ability, and Quality of Life in Breast Cancer Survivors: A Cross-Sectional Study
    Nan Wu, Ze Luan, Zijun Zhou, He Wang, Shiyuan Du, Yulu Chen, Xinxin Wang, Jiong Li, Xin Peng
    Seminars in Oncology Nursing.2024; 40(5): 151690.     CrossRef
  • Effects of different exercise interventions on chemotherapy-related cognitive impairment in patients with breast cancer: a study protocol for systematic review and network meta-analysis
    Yu Dong, Hao Huang, Aiping Wang
    BMJ Open.2024; 14(4): e078934.     CrossRef
  • Factors Associated with Self-reported Memory Problems of Adult Cancer Survivors Based on the Korea National Health and Nutrition Examination Survey 2019
    Sangjin Ko
    Journal of Health Informatics and Statistics.2023; 48(1): 51.     CrossRef
  • Impact of nonpharmacological interventions on cognitive impairment in women with breast cancer: A systematic review and meta-analysis
    Jin-Hee Park, Su Jin Jung, Lena J. Lee, Junghyun Rhu, Sun Hyoung Bae
    Asia-Pacific Journal of Oncology Nursing.2023; 10(4): 100212.     CrossRef
  • Impact of discriminant factors on the comfort-care of nurses caring for trans-arterial chemoembolisation patients
    Myoung Soo Kim, Ju-Yeon Uhm
    Supportive Care in Cancer.2022; 30(9): 7773.     CrossRef
  • Brain morphological alterations and their correlation to tumor differentiation and duration in patients with lung cancer after platinum chemotherapy
    Pin Lv, Guolin Ma, Wenqian Chen, Renyuan Liu, Xiaoyan Xin, Jiaming Lu, Shu Su, Ming Li, ShangWen Yang, Yiming Ma, Ping Rong, Ningyu Dong, Qian Chen, Xin Zhang, Xiaowei Han, Bing Zhang
    Frontiers in Oncology.2022;[Epub]     CrossRef
  • The Influence of Rehabilitation on Quality of Life in Breast Cancer Survivors: A Clinical Study
    Teresa Paolucci, Aristide Saggino, Francesco Agostini, Marco Paoloni, Andrea Bernetti, Massimiliano Mangone, Valter Santilli, Raoul Saggini, Marco Tommasi
    International Journal of Environmental Research and Public Health.2021; 18(16): 8585.     CrossRef
  • 363 View
  • 3 Download
  • 8 Web of Science
  • 9 Crossref
Close layer
Effect of Cancer Symptoms and Fatigue on Chemotherapy-related Cognitive Impairment and Depression in People with Gastrointestinal Cancer
Pok Ja Oh, Jung Ran Lee
J Korean Acad Nurs 2016;46(3):420-430.   Published online June 30, 2016
DOI: https://doi.org/10.4040/jkan.2016.46.3.420
AbstractAbstract PDF
Purpose

The purpose of this study was to test a hypothetical model of chemotherapy-related cognitive impairment (CRCI) and depression in people with gastrointestinal cancer.

Methods

A purposive sample of 198 patients undergoing chemotherapy was recruited from November 2014 to July 2015. The instruments were Everyday Cognition (ECog), Hospital Anxiety Depression Scale (HADS), Functional Assessment of Chronic Illness Therapy-Fatigue (FACIT-F), and M. D. Anderson Symptom Inventory-Gastrointestinal Cancer Module. Data were analyzed using descriptive statistics, correlation, and path analysis.

Results

CRCI was directly affected by cancer symptoms (β=.19, p=.004) and fatigue (β=.56, p<.001)(R2=47.2%). Depression was directly affected by fatigue (β=.48, p<.001) and CRCI (β=.27, p<.001). However, The impact of cancer symptoms on depression was confirmed through the mediating effect of CRCI.

Conclusion

Results indicate that in patients with gastrointestinal cancer undergoing chemotherapy along with the direct physiologic effects (fatigue, symptoms) of cancer treatment may have altered cognitive function leading to depression.

Citations

Citations to this article as recorded by  
  • Low Back Pain and Its Influencing Factors among Intensive Care Unit Nurses: A Cross-sectional Study
    Hyun Ju Uhm, Hye-Ja Park
    Journal of Health Informatics and Statistics.2022; 47(2): 95.     CrossRef
  • Factors affecting the quality of life of gastric cancer survivors
    Jahyun Choi, Sanghee Kim, Mona Choi, Woo Jin Hyung
    Supportive Care in Cancer.2022; 30(4): 3215.     CrossRef
  • Attitudes About Coping With Fatigue in Patients With Gastric Cancer
    Eun Ja Yeun, Misoon Jeon
    Gastroenterology Nursing.2020; 43(1): 97.     CrossRef
  • Symptom Distress and Depression in Patients with Recurrent Gynecologic Cancer Undergoing Chemotherapy: Mediating Effect of Resilience
    Eun Jung Yang, Ho Sihn Ryu
    Korean Journal of Adult Nursing.2019; 31(1): 28.     CrossRef
  • Computerized programs for cancer survivors with cognitive problems: a systematic review
    Yoonjung Kim, Sook Jung Kang
    Journal of Cancer Survivorship.2019; 13(6): 911.     CrossRef
  • Changes of Cognitive Function and Depression following Chemotherapy in Women with Breast Cancer: A Prospective Study
    Pok Ja Oh, Jung Ran Lee, Hyun Ah Kim
    Asian Oncology Nursing.2018; 18(2): 66.     CrossRef
  • Symptom Clusters and Quality of Life in Subjects With COPD
    Kyeung Eun Lim, Sung Reul Kim, Hyun Kyung Kim, So Ri Kim
    Respiratory Care.2017; 62(9): 1203.     CrossRef
  • 170 View
  • 2 Download
  • 7 Crossref
Close layer

J Korean Acad Nurs : Journal of Korean Academy of Nursing
Close layer
TOP